Modest benefit has been shown from transdermal testosterone therapy given to postmenopausal women with reduced sexual desire. An increased frequency of satisfying sexual encounters and intensity of sexual desire and response has been shown in medically and psychiatrically healthy women able to have 2—3 satisfying sexual experiences each month before therapy commences. Women more clearly sexually dysfunctional in keeping with currently proposed definitions of sexual disorder have not been studied. Numerous factors are known to influence women’s sexual desire with mood and feelings towards the partner showing the most robust associations. How to identify women whose low desire might stem from low testosterone activity remains unknown: neither serum levels of testosterone nor its metabolites correlate with desire or function. Production of androgens in the brain, sensitivity of the androgen receptors, and activity of cofactors are all potentially relevant confounds. The long-term safety of systemic testosterone with or without estrogen is unknown but necessary as women’s sexual lives tend to endure as long as there is an active partner.
Arlt, W. ( 2006) Androgen therapy in women. Eur J Endocrinol154: 1-11.
2.
Avis, N.E., Zhao, X., Johannes, C.B., Ory, M., Brockwell, S. and Greendale, G.A. ( 2005) Correlates of sexual function among multi ethnic middle aged women: Results from the study of women’s health across the nation (SWAN). Menopause12: 385-398.
3.
Aziz, A., Brannstrom, M., Bergquist, C. and Silfverstople, G. ( 2005) Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertil Steril83: 1021-1028.
4.
Bancroft, J., Loftus, J. and Long, J.S. ( 2003) Distress about sex: A national survey of women in heterosexual relationships. Arch Sex Behav32: 193-211.
5.
Barton, D.L., Wender, D.B., Sloan, J.A., Dalton, R.J., Balcueva, E.P., Atherton, P.J. et al. (2007) Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3. J Natl Cancer Inst99: 672-679.
6.
Basson, R. ( 2001) Female sexual response: The role of drugs in the management of sexual dysfunction. Obstet Gynecol98: 350-352.
7.
Basson, R. ( 2000) The female sexual response: A different model. J Sex Marital Ther26: 51-65.
8.
Basson, R. ( 2006) Clinical practice: Sexual desire and arousal disorders in women. New Engl J Med354: 1467-1506.
9.
Basson, R., Brotto, L.A., Petkau, J. and Labrie, F. ( 2010) Role of androgens in women’s sexual dysfunction . Menopause, DOI: 10.1097/ gme.0b013e3181d59765.
10.
Basson, R., Rees, P., Wang, R., Montejo, A.L. and Incrocci, L.(2010) Sexual function in chronic illness. J Sex Med7: 374-388.
11.
Bitzer, J., Kenemans, P. and Mueck, A.O. ( 2008) Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy. Maturitas59: 209-218.
12.
Bozman, A.W. and Beck, J.G. ( 1991) Covariation of sexual desire and sexual arousal: The effects of anger and anxiety. Arch Sex Behav20: 47-60.
13.
Brand, J.S. and van der Schouw, Y.T.(2010) Testosterone, SHBG and cardiovascular health in postmenopausal women . Int J Impot Res22: 91-104.
14.
Braunstein, G., Sundwall, D.A., Katz, M., Shifren, J.L., Buster, J.E., Simon, J.A. et al. (2005) Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch Intern Med165: 1582-1589.
15.
Brotto, L.A. ( 2010) The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sex Behav39: 221-239.
16.
Brotto, L.A., Heiman, J.R. and Tolman, D.(2009) Narratives of desire in mid-age women with and without arousal difficulties . J Sex Res46: 387-398.
17.
Buster, J.E., Kingsberg, S.A., Aguirre, O., Brown, C., Breaux, J.G., Buch, A. et al. (2005) Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol105: 944-952.
18.
Cain, V.S., Johannes, C.B., Avis, N.E., Mohr, B., Schocken, M., Skurnick, J. et al. (2003) Sexual functioning and practices in a multi-ethnic study of midlife women: Baseline results from SWAN. J Sex Res40: 266-276.
19.
Chivers, M.L., Seto, M.C., Lalumière, M.L., Laan, E. and Grimbos, T.(2010) Agreement of self-reported and genital measures of sexual arousal in men and women: A meta-analysis. Arch Sex Behav39: 5-56.
20.
Clayton, A., Kornstein, S., Prakash, A., Mallinckrodt, C. and Wohlreich, M. ( 2007) Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med4: 917-929.
21.
Davis, S., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M. et al. (2008a) Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med359: 2005-2017.
22.
Davis, S., Papalia, M.A., Norman, R.J., O’Neill, S., Redelman, M., Williamson, M. et al. (2008b) Safety and efficacy of a testosterone metered-dose transdermal spray for treatment of decreased sexual satisfaction in premenopausal women: A placebo-controlled randomized, dose ranging study. Ann Intern Med148: 569-577.
23.
Davis, S.R., Davison, S.L., Donath, S. and Bell, R.J. ( 2005) Circulating androgen levels in self-reported sexual function in women. JAMA294: 91-96.
24.
Davis, S.R., Nijland, F.A. and Weijmar-Schultz, W. ( 2006a) Tibolone vs. transdermal continuous combined estrogen plus progestin in the treatment of female sexual dysfunction in naturally menopausal women: Results from the NETA trial. Maturitas554(Suppl): S1-S112.
25.
Davis, S.R., van der Mooren, M.J., van Lunsen, R.H.W., Lopes, P., Ribot, C., Rees, M. et al. (2006b) Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo controlled-trial. Menopause13: 387-396.
26.
Davison, S.L., Bell, R., Donath, S., Montalto, J.G. and Davis, S.R. ( 2005) Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab90: 3847-3853.
27.
Dennerstein, L., Dudley, E. and Burger, H. ( 2001) Are changes in sexual functioning during mid-life due to aging or menopause? Fertil Steril76: 456-460.
28.
Dennerstein, L., Koochaki, P., Barton, I. and Graziottin, A. ( 2006) Hypoactive sexual desire disorder in menopausal women: A survey of westernEuropean women. J Sex Med3: 212-222.
29.
DBT (2009) Testosterone patches for female sexual dysfunction. Drug Ther Bull47: 30-34.
30.
Farquhar, C.M., Harvey, S.A., Yu, Y., Sadler, L. and Stewart, A.W. ( 2006) A prospective study of three years of outcomes after hysterectomy with and without oophorectomy. Am J Obstet Gynecol194: 711-717.
31.
Goldstat, R., Briganti, E., Tran, J., Wolfe, R. and Davis, S.R. ( 2003) Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause10: 390-398.
32.
Graham, C.A. ( 2010) The DSM diagnostic criteria for female sexual arousal disorder. Arch Sex Behav39: 240-255.
33.
Hartmann, U., Philippsohn, S., Heiser, K. and Rüffer-Hesse, C. ( 2004) Low desire in midlife and older women: Personality factors, psychosocial development, present sexuality. Menopause11: 726-740.
34.
Hayes, R.D. ( 2008) Assessing female sexual dysfunction in epidemiological studies: Why is it necessary to measure both low sexual function and sexually related distress? Sex Health5: 215-218.
35.
Ishunina, T.A. and Swaab, D.F. ( 2007) Alterations in the human brain in menopause. Maturitas57: 20-22.
36.
Janssen, E., Everaerd, W., Spiering, M. and Janssen, J. ( 2000) Automatic processes and the appraisal of sexual stimuli: Toward an information processing model of sexual arousal. J Sex Res37: 8-23.
37.
Kennedy, S.H., Dickens, S.C., Eisfeld, B.S. and Bagby, R.M. ( 1999) Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord56: 201-208.
38.
Kingsberg, S., Shifren, J., Wekselman, K., Rodenberg, C., Koochaki, P. and DeRogatis, L. ( 2007) The evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med4: 1001-1008.
39.
Klusmann, D. ( 2002) Sexual motivation and the duration of partnership . Arch Sex Behav31: 275-287.
40.
Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.L. et al. (2009) Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause16: 923-931.
41.
Labrie, F., Bélanger, A., Tusan, L., Cusan, L. and Candas, B. ( 1997) Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging . J Clin Endocrinol Metab82: 2396-2402.
42.
Leiblum, S.R., Koochaki, P.E., Rodenberg, C.A., Barton, I.P. and Rosen, R.C. ( 2006) Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause13: 46-56.
43.
Li, J. and Al-Azzawi, F.(2009) Mechanism of androgen receptor action. Maturitas63: 142-148.
44.
Lutfey, K.E., Link, C.L., Rosen, R.C., Wiegel, M. and McKinlay, J.B.(2009) Prevalence and correlates of sexual activity and function in women: Results from the Boston Area Community Health (BACH) Survey. Arch Sex Behav38: 514-527.
45.
McCall, K. and Meston, C. ( 2007) Differences between pre- and postmenopausal women in cues for sexual desire. J Sex Med4: 364-371.
46.
Melcangi, R.C., Garcia-Segura, L.M. and Mensah-Nygan, A.G. ( 2008) Neuroactive steroids: State of the art and new perspectives . Cell Mol Life Sci65: 777-797.
47.
Meston, C.M. and Buss, D.M. ( 2007) Why humans have sex. Arch Sex Behav36: 477-507.
48.
Nachtigall, L., Casson, P., Lucas, J., Melson, C. and Schofield, V. ( 2006) Safety and tolerability of transdermal testosterone systems (TTS) in surgically menopausal women receiving oral or transdermal estrogen over 36-months of therapy. Menopause13: 1022.
49.
Panay, N., Al-Azzawi, F., Bouchard, C., Davis, S.R., Eden, J., Lodhi, I. et al. (2010) Testosterone treatment of HSDD in naturally menopausal women: The ADORE study. Climacteric13: 121-131.
50.
Sanders, S.A., Graham, C.A. and Milhausen, R.R. ( 2008) Predicting sexual problems in women: The relevance of sexual excitation and sexual inhibition. Arch Sex Behav38: 241-251.
51.
Santoro, N., Torrens, J., Crawford, S., Allsworth, J.E., Finkelstein, J.S., Gold, E.B. et al. (2005) Correlates of circulating androgens in midlife women: The study of women’s health across the nation. J Clin Endocrinol Metab90: 4836-4845.
52.
Shifren, J.L., Davis, S.R., Moreau, M., Waldbaum, A., Bouchard, C., DeRogatis, L. et al. (2006) Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 STUDY. Menopause13: 770-779.
53.
Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S. et al. (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder . J Clin Endocrinol Metab90: 5226-5233.
54.
Slob, A.K., Bax, C.M., Hop, W.C.J., Rowland, D.L. and van der Werfften Bosch, J.J. (1996) Sexual arousability and the menstrual cycle . Psychoneuroendocrinology21: 545-558.
55.
Snabes, M.C. and Simes, S.M.(2009) Approved hormonal treatments for HSDD: An unmet medical need . J Sex Med6: 1846-1849.
56.
Teplin, V., Vittinghoff, E., Lin, F., Learman, L.A., Richter, H.E. and Kuppermann, M. ( 2007) Oophorectomy in premenopausal women: Health-related quality of life and sexual functioning. Obstet Gynecol109: 347-354.
57.
ter Kuile, M.M., Both, S. and van Uden, J. ( 2010) The effects of experimentally induced sad and happy mood on sexual arousal in sexually healthy women. J Sex Med7: 1177-1184.
58.
Toates, F. ( 2009) An integrative theoretical framework for understanding sexual motivation, arousal, and behaviour. J Sex Res46: 168-193.
59.
Weiss, E.L., Bowers Jr, M.B. and Mazure, C.M. ( 1999) Testosterone-patch-induced psychotic mania. Am J Psychiatry156: 969.
60.
West, S.L., D’Aloisio, A.A., Agans, R.P., Kalsbeek, W.D., Borisov, N.N. and Thorp, J.M. ( 2008) Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med168: 1441-1449.
61.
Wierman, M.E., Basson, R., Davis, S.R., Khosla, S., Miller, K., Rosner, W. et al. (2006) Androgen therapy in women: An Endocrine Society Clinical Practice Guideline. J Clin Enocrinol Metab1: 3697-3710.
